Area riservata
| FDA Approves Drug For Common Skin Cancer |
| Scritto da Dermatology News From Medical News Today |
 On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge...Fonte: Dermatology News From Medical News Today |